Miwa K

No ORCID on file · 4 papers in corpus · active 1991-2014

Study types

  • other 2
  • article 1
  • case-report 1

Condition tags

  • endometriosis 4
other 2014
Suppression of the hypothalamic-pituitary-gonadal axis by TAK-385 (relugolix), a novel, investigational, orally active, small molecule gonadotropin-releasing hormone (GnRH) antagonist: studies in human GnRH receptor knock-in mice
European journal of pharmacology ·doi:10.1016/j.ejphar.2013.12.001

TAK-385 (relugolix) is a novel, non-peptide, orally active gonadotropin-releasing hormone (GnRH) antagonist, which builds on previous work with non-peptide GnRH antagonist TAK-013. TAK-385 possesses higher affinity and more potent antagonis…

article 2007
Successful Video-Assisted Thoracic Surgery for Pulmonary Endometriosis: Report of a Case
Surgery today ·doi:10.1007/s00595-006-3360-0

Pulmonary endometriosis is a disease in which uterine endometrial cells with stromal components grow in the pulmonary parenchymal tissues or pleura. Surgical resection is considered an effective and radical treatment for pulmonary endometri…

case-report 2001
Adenomyomatosis of the papilla of Vater: a case illustrating diagnostic difficulties
Digestive surgery ·doi:10.1159/000050115

AIMS: To describe the extremely rare case of an adenomyoma of the papilla of Vater. CASE REPORT: A 42-year-old woman was hospitalized for epigastralgia and high fever. The clinical presentation and endoscopic, biochemical, and radiologic f…

other 1991
[The prognosis of ovarian cancer depends on the CA125 value at the end of induction therapy]
Nihon Sanka Fujinka Gakkai zasshi

The prognosis of ovarian cancer depends on the CA125 value at the end of induction therapy. The relationship between the prognosis and the CA125 value at the end of induction therapy was analysed in 16 ovarian cancers. In the group with a C…